QQQ $ 482.51 $ 2.62 (0.55 %)
DIA $ 391.46 $ 0.62 (0.16 %)
SPY $ 545.42 $ 1.68 (0.31 %)
TLT $ 90.51 $ -0.16 (-0.18 %)
GLD $ 215.68 $ 0.41 (0.19 %)
$ 0.0001
-- x --
-- x --
-- - --
$ 0.00 - $ 0.03
561
na
na
$ 1.09
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ma-fl-and-oh-psychedelics-scientists-and-educators-latest-research-and-views

Along with a growing scientific corpus supporting the therapeutic potential of psychedelics, several states and most noticeably...

 exclusive-in-reinventing-mental-health--next-gen-psychedelics-access-and-clinical-data-are-key

Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutioni...

 psyched-psychedelic-therapy-in-the-workplace-ucls-brain-imaging-study-compass-trials-and-more

Psychedelic Therapy Now Available As Workplace Benefit, Free Month For Laid-Off Tech Workers

 psychedelics--environmental-protection-company-seeks-patents-to-synthetically-produce-toad-venom

Psychedelic therapeutics biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed three additional U.S.

 psychedelics-production-methods-expect-further-ip-protection-with-4-new-patents

Biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed four new U.S. Patent Cooperation Treaty (PCT) applications a...

 psyched-fed-guidelines-and-research-production-quotas-protests-in-canada-cals-decrim-project

Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIM...

 psybio-therapeutics-reports-interim-third-quarter-2022-financial-results

PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) reported its unaudited interim financial results for the three and nine-m...

 yeast-produces-bread-and-psilocybin-this-company-is-moving-into-clinical-trial-phase

The current clinical scenario sets psilocybin as one of the most advanced psychedelics, expected to become legally approved in ...

 most-but-not-all-psychedelics-companies-have-sufficient-liquidity

The Chart represents the liquidity positions of the 21 Psychedelic sector companies in the Viridian Value Tracker database.

 dmt-producer-psybio-and-shrooms-grower-red-light-holland-share-their-most-recent-financial-results

PsyBio Therapeutics (TSXV: PSYB) (OTCQB: PSYBF), a biotech developing medicines based on naturally-occurring psychedelic substa...

 cannabis-movers--shakers-burns--levinson-water-ways-chill-brands-rubicon-organics

Burns & Levinson Expands National Cannabis Business Law Practice  Boston-based Burns & Levinson LLP announced Tuesday ...

 psyched-the-50-publicly-listed-psychedelics-companies-atais-new-subsidiary-pharmather-gets-new-orphan-drug-designation

The Week In Psychedelics

 there-are-now-50-psychedelics-companies-listed-in-the-us---here-they-are

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking in...

 psyched-delic-buys-10-ketamine-clinics-for-10m-atai-launches-ibogaine-human-trials-small-pharma-concludes-phase-1-dmt-study

The Week In Psychedelics:

 psyched-gh-research-debuts-on-nasdaq-compass-reaches-psilocybin-research-milestone-maxim-gives-buy-rating-to-10-psychedelics-companies

Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential of 5-MeO-DMT f...

 maxim-group-gives-buy-rating-to-10-psychedelic-stocks-compass-mindmed-cybin-field-trip-and-more

Institutional analysts are taking a liking to the industry of medicinal psychedelics. This week, investment bank Maxim Group in...